Literature DB >> 17709391

A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling.

Hirochika Kitagawa1, William J Ray, Helmut Glantschnig, Pascale V Nantermet, Yuanjiang Yu, Chih-Tai Leu, Shun-ichi Harada, Shigeaki Kato, Leonard P Freedman.   

Abstract

The orphan nuclear receptor Nurr1 is essential for the development and maintenance of midbrain dopaminergic neurons, the cells that degenerate during Parkinson's disease, by promoting the transcription of genes involved in dopaminergic neurotransmission. Since Nurr1 lacks a classical ligand-binding pocket, it is not clear which factors regulate its activity and how these factors are affected during disease pathogenesis. Since Wnt signaling via beta-catenin promotes the differentiation of Nurr1(+) dopaminergic precursors in vitro, we tested for functional interactions between these systems. We found that beta-catenin and Nurr1 functionally interact at multiple levels. In the absence of beta-catenin, Nurr1 is associated with Lef-1 in corepressor complexes. Beta-catenin binds Nurr1 and disrupts these corepressor complexes, leading to coactivator recruitment and induction of Wnt- and Nurr1-responsive genes. We then identified KCNIP4/calsenilin-like protein as being responsive to concurrent activation by Nurr1 and beta-catenin. Since KCNIP4 interacts with presenilins, the Alzheimer's disease-associated proteins that promote beta-catenin degradation, we tested the possibility that KCNIP4 induction regulates beta-catenin signaling. KCNIP4 induction limited beta-catenin activity in a presenilin-dependent manner, thereby serving as a negative feedback loop; furthermore, Nurr1 inhibition of beta-catenin activity was absent in PS1(-/-) cells or in the presence of small interfering RNAs specific to KCNIP4. These data describe regulatory convergence between Nurr1 and beta-catenin, providing a mechanism by which Nurr1 could be regulated by Wnt signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709391      PMCID: PMC2169041          DOI: 10.1128/MCB.00409-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting.

Authors:  Anna Codina; Gerard Benoit; John T Gooch; David Neuhaus; Thomas Perlmann; John W R Schwabe
Journal:  J Biol Chem       Date:  2004-09-28       Impact factor: 5.157

2.  Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.

Authors:  Heidar Alimohamad; Nagalingam Rajakumar; Yam-Hong Seah; Walter Rushlow
Journal:  Biol Psychiatry       Date:  2005-03-01       Impact factor: 13.382

Review 3.  Controlling nuclear receptors: the circular logic of cofactor cycles.

Authors:  Valentina Perissi; Michael G Rosenfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

4.  Nurr1 in Parkinson's disease and related disorders.

Authors:  Yaping Chu; Weidong Le; Katie Kompoliti; Joseph Jankovic; Elliott J Mufson; Jeffrey H Kordower
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

5.  Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer.

Authors:  Vijaykumar R Holla; Jason R Mann; Qiong Shi; Raymond N DuBois
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

6.  The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.

Authors:  H Alimohamad; L Sutton; J Mouyal; N Rajakumar; W J Rushlow
Journal:  J Neurochem       Date:  2005-09-02       Impact factor: 5.372

7.  Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.

Authors:  Rajan Singh; Jorge N Artaza; Wayne E Taylor; Melissa Braga; Xin Yuan; Nestor F Gonzalez-Cadavid; Shalender Bhasin
Journal:  Endocrinology       Date:  2005-10-06       Impact factor: 4.736

Review 8.  Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?

Authors:  David J Mulholland; Shoukat Dedhar; Gerhard A Coetzee; Colleen C Nelson
Journal:  Endocr Rev       Date:  2005-08-26       Impact factor: 19.871

Review 9.  Wnt signaling: complexity at the surface.

Authors:  Ken M Cadigan; Yan I Liu
Journal:  J Cell Sci       Date:  2006-02-01       Impact factor: 5.285

10.  MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling.

Authors:  Joanne Darragh; Ana Soloaga; Victoria A Beardmore; Andrew D Wingate; Giselle R Wiggin; Mark Peggie; J Simon C Arthur
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

View more
  27 in total

Review 1.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

2.  Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.

Authors:  Daren Low; Ken-Shiung Chen
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

Review 3.  NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.

Authors:  Yue Zhao; Dennis Bruemmer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08       Impact factor: 8.311

4.  Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers.

Authors:  Yi-Fang Han; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

5.  Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.

Authors:  Olga Fedorova; Alexey Petukhov; Alexandra Daks; Oleg Shuvalov; Tatyana Leonova; Elena Vasileva; Nikolai Aksenov; Gerry Melino; Nikolai A Barlev
Journal:  Oncogene       Date:  2018-11-19       Impact factor: 9.867

6.  Coactivation of estrogen receptor beta by gonadotropin-induced cofactor GIOT-4.

Authors:  Madoka Kouzu-Fujita; Yoshihiro Mezaki; Shun Sawatsubashi; Takahiro Matsumoto; Ikuko Yamaoka; Tetsu Yano; Yuji Taketani; Hirochika Kitagawa; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

7.  Downstream targets of GATA3 in the vestibular sensory organs of the inner ear.

Authors:  David M Alvarado; Rose Veile; Judith Speck; Mark Warchol; Michael Lovett
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

Review 8.  Rogue proliferation versus restorative protection: where do we draw the line for Wnt and forkhead signaling?

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Expert Opin Ther Targets       Date:  2008-07       Impact factor: 6.902

Review 9.  ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease.

Authors:  Manish Verma; Erin K Steer; Charleen T Chu
Journal:  Biochim Biophys Acta       Date:  2013-11-10

Review 10.  Wnt your brain be inflamed? Yes, it Wnt!

Authors:  Bianca Marchetti; Stefano Pluchino
Journal:  Trends Mol Med       Date:  2013-01-09       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.